SCHEMBL4898017

SCHEMBL4898017

CCN(c1nc(-c2ccccc2)sc1C)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.41
RARA P10276 1/20 0.39
RARB P10826 1/20 0.39
RARG P13631 1/20 0.39
TRPM8 Q7Z2W7 2/20 0.39
TP53 P04637 1/20 0.38
CDC7 O00311 2/20 0.37
DBF4 Q9UBU7 2/20 0.37
ESR1 P03372 1/20 0.37
ALDH1A1 P00352 6/20 0.37
KMT2A Q03164 4/20 0.37
LMNA P02545 3/20 0.37
HTT P42858 1/20 0.37
TSHR P16473 1/20 0.36
KDM4E B2RXH2 4/20 0.36
GAA P10253 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MEN1 O00255 2/20 0.36
MAPT P10636 1/20 0.36
NLRP1 Q9C000 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4899693 0.93 TP53 (0.40) TRPM8TP53CDC7DBF4ALDH1A1
SCHEMBL4906570 0.91 SLC6A3 (0.39) RARARARBRARGTRPM8TP53
SCHEMBL4901291 0.91 ALDH1A1 (0.39) L3MBTL1TRPM8TP53ALDH1A1KMT2A
SCHEMBL4895425 0.91 TRPM8 (0.39) L3MBTL1TRPM8TP53CDC7DBF4
SCHEMBL4903806 0.91 LMNA (0.42) L3MBTL1RARARARBRARGTRPM8
SCHEMBL4895175 0.89 MAPT (0.36) L3MBTL1TRPM8CDC7DBF4ALDH1A1
SCHEMBL4900544 0.89 KDM4E (0.41) L3MBTL1TP53ALDH1A1KMT2ALMNA
SCHEMBL4907657 0.88 TRPM8 (0.41) TRPM8
SCHEMBL4906433 0.86 ALDH1A1 (0.39) L3MBTL1RARARARBRARGTP53
SCHEMBL4903647 0.84 ALDH1A1 (0.39) RARARARBRARGTRPM8TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD L3MBTL1 1234/4885RARA 470/4885RARB 513/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD L3MBTL1 1246/4885RARA 431/4885RARB 531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.